524564 GAYATRIBI

Gayatri BioOrganics Share Price

 

 

Start SIP in GAYATRIBI

Start SIP

Performance

  • Low
  • ₹16
  • High
  • ₹16
  • 52 Week Low
  • ₹5
  • 52 Week High
  • ₹20
  • Open Price₹16
  • Previous Close₹17
  • Volume10,802

Investment Returns

  • Over 1 Month + 26.43%
  • Over 3 Month + 28.78%
  • Over 6 Month + 104.49%
  • Over 1 Year + 127.25%

Smart Investing Starts Here Start SIP with Gayatri BioOrganics for Steady Growth!

Invest Now

Gayatri BioOrganics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -155.1
  • PEG Ratio
  • 25.7
  • Market Cap Cr
  • 126
  • P/B Ratio
  • -3.5
  • Average True Range
  • 0.94
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.3
  • RSI
  • 53.38
  • MFI
  • 66.22

Gayatri BioOrganics Financials

Gayatri BioOrganics Technicals

EMA & SMA

Current Price
₹15.93
-0.83 (-4.95%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹15.97
  • 50 Day
  • ₹14.20
  • 100 Day
  • ₹12.72
  • 200 Day
  • ₹10.96

Resistance and Support

16.05 Pivot Speed
  • R3 16.55
  • R2 16.42
  • R1 16.18
  • S1 15.81
  • S2 15.68
  • S3 15.44

Gayatri BioOrganics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-07-29 Quarterly Results
2025-05-28 Audited Results
2025-01-20 Quarterly Results
2024-11-11 Quarterly Results

Gayatri BioOrganics F&O

Gayatri BioOrganics Shareholding Pattern

21.59%
0.65%
0.01%
52.94%
24.81%

Gayatri BioOrganics FAQs

Gayatri BioOrganics share price is ₹15 As on 04 January, 2026 | 22:01

The Market Cap of Gayatri BioOrganics is ₹125.5 Cr As on 04 January, 2026 | 22:01

The P/E ratio of Gayatri BioOrganics is -155.1 As on 04 January, 2026 | 22:01

The PB ratio of Gayatri BioOrganics is -3.5 As on 04 January, 2026 | 22:01

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23